SANDF applies to SAHPRA to trial illegally imported Cuban drug

Organisation: Position: Deadline Date: Location:

The South African military will apply to run a clinical trial for the use of a drug known as Heberon to tackle COVID-19, ending a dispute over the illegal importation of the medicine by the South African National Defence Force, the health products regulator said.

The drug, a Cuban product that contains recombinant human interferon alpha-2b, has been touted as a potential treatment for the coronavirus, notes a BusinessTech report.

It has been used to treat various forms of cancer and leukaemia. The application will be examined by the South African Health Products Regulator, it said in a statement last week.

The dispute began when the regulator became aware of the arrival of the drug in the country in November.

 

Full BusinessTech report

 

See also MedicalBrief archives:

Hawks and SAHPRA raid for ‘COVID cure’ blocked by SANDF

 

AG: SANDF already paid some of R260m for Cuban COVID ‘wonder cure’

 

Cuban anti-COVID drug cost R200m and used on only 1 patient

 

SANDF spends R200m on unapproved Cuban COVID drug

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.